T1	Disease	30 61	Dukes ' C colorectal cancer who
T2	Disease	81 102	surgical resection of
T3	Disease	115 132	tumour , followed
T4	Chemical	138 173	FU -based adjuvant chemotherapy , p
T5	Limited_variation	173 203	53 mutation status as assessed
T6	Phenotype	253 291	overall and metastasis-free survival .
R1	treats	Arg1:T1	Arg2:T3
R2	isAssociatedWith	Arg1:T1	Arg2:T5
R3	treats	Arg1:T2	Arg2:T1
R4	treats	Arg1:T2	Arg2:T3
R5	influences	Arg1:T2	Arg2:T4
R6	isAssociatedWith	Arg1:T2	Arg2:T5
R7	influences	Arg1:T2	Arg2:T6
R8	treats	Arg1:T3	Arg2:T1
R9	influences	Arg1:T3	Arg2:T2
R10	influences	Arg1:T3	Arg2:T4
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	influences	Arg1:T3	Arg2:T6
R13	treats	Arg1:T4	Arg2:T1
R14	influences	Arg1:T4	Arg2:T2
R15	treats	Arg1:T4	Arg2:T3
R16	isAssociatedWith	Arg1:T4	Arg2:T5
R17	influences	Arg1:T4	Arg2:T6
R18	influences	Arg1:T5	Arg2:T2
R19	influences	Arg1:T5	Arg2:T3
R20	influences	Arg1:T5	Arg2:T4
R21	influences	Arg1:T5	Arg2:T6
R22	isAssociatedWith	Arg1:T6	Arg2:T1
R23	isAssociatedWith	Arg1:T6	Arg2:T2
R24	isAssociatedWith	Arg1:T6	Arg2:T3
R25	isAssociatedWith	Arg1:T6	Arg2:T4
R26	isAssociatedWith	Arg1:T6	Arg2:T5
